Embraer books ‘milestone’ SkyWest deal worth up to $8.3 billion

Tuesday, May 21st, 2013 | Finance News

By Brad Haynes

SAO PAULO (Reuters) - SkyWest Inc , the world's largest regional airline group, agreed to buy at least 40 new jets from Brazilian planemaker Embraer SA , in a deal that could climb to 200 aircraft and a total price tag of more than $8 billion.

"This is truly a milestone order for Embraer," Paulo Cesar de Souza e Silva, the head of Embraer's commercial aviation unit, said in a Tuesday announcement calling the deal one of the biggest ever for both companies.

The first 40 E175s, which SkyWest will fly for United Airlines , enter directly into Embraer's order backlog, while orders for another 60 planes depend on the operator's upcoming contracts with major airlines. SkyWest also has options for an additional 100 aircraft, bringing the potential value of the contract to $8.3 billion at list prices.

With that, Embraer has all but guaranteed the rebound of its commercial aircraft division, which had slumped to about half of revenue as the company trimmed production on weak order flow.

Embraer shares jumped as much as much as 4.8 percent in early Sao Paulo trading to their highest in over five years.

The order also secures Embraer's lead over its chief rival, Canada's Bombardier Inc , in the race for new orders from major U.S. airlines, who are snapping up planes with up to 76 seats due to labor contracts renegotiated last year.

"This announcement further entrenches Embraer's lead with regards to the current regional jet campaign with major North American carriers," analyst Walter Spracklin of RBC Dominion Securities wrote in a note.

Embraer already booked an order directly with United Continental Holdings Inc last month for as many as 70 new regional jets. That guaranteed stable production in the coming year, executives said, and boosted the chances that output would rise as much as 15 percent next year to around 2012 levels.

Combined with an order for the American Airlines network, Embraer has booked 117 firm orders and 247 options and conditional orders with U.S. carriers this year.

Bombardier's last major contract with a U.S. airline was a December deal with Delta Air Lines for 40 firm orders and 30 options. Canadian carrier Porter Airlines has also placed a conditional order for 12 of Bombardier's CSeries jets, including options for another 18, pending the expansion of its Toronto Island airport base.

Embraer's deliveries on the SkyWest contract are set to begin in the second half of 2014.

(Reporting by Brad Haynes; Additional reporting by Susan Taylor in Toronto and Bangalore Newsroom; Editing by Maureen Bavdek and Marguerita Choy)

Source

Apple’s Cook to face Senate questions on taxes

Tuesday, May 21st, 2013 | Finance News

WASHINGTON (AP) — A Senate panel says Apple Inc. is avoiding paying billions of dollars in U.S. taxes by using a cluster of affiliates located outside the United States and is prepared to question its chief executive Tuesday about the "loopholes."

Apple CEO Tim Cook is expected to explain the company's tax strategy to the Senate Permanent Subcommittee on Investigations, which released a detailed report Monday on the company's practices.

The world's most valuable company says it is complying with the laws and pays "an extraordinary amount" in U.S. taxes.

Sen. Carl Levin, D-Mich., the panel's chairman, says Apple's capitalizing on loopholes in the U.S. tax code is unique among multinational corporations.

"Apple is exploiting an absurdity," Levin said at the start of the hearing.

.

.

Source

France: Drugmaker on trial, suspected in deaths

Tuesday, May 21st, 2013 | Finance News

NANTERRE, France (AP) — A French drug company and its founder are on trial on charges of misleading the public about a diabetes drug marketed as a weight loss method and suspected in hundreds of deaths.

But after years of delays in one of France's biggest recent health scandals, the proceedings could still be pushed back further.

Between 1976 and 2009, around 5 million people took Mediator, designed as a diabetes drug but widely promoted for weight loss. Mediator's creators, Servier Laboratories, face charges of "aggravated deception" in a trial that opened Tuesday in Nanterre, outside Paris.

Some victims and their families want a speedy trial, hoping a conviction would move forward their claims for damages.

Others, including Servier, want judges to delay proceedings while a separate manslaughter investigation is still underway in Paris.

Source